| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |